Presentation on theme: "Acute Tonsillopharyngitis Dr Rajesh 16/04/08. Definitions tonsillitis: inflammation of pharyngeal tonsils tonsillopharyngitis: inflammation extending."— Presentation transcript:
Acute Tonsillopharyngitis Dr Rajesh 16/04/08
Definitions tonsillitis: inflammation of pharyngeal tonsils tonsillopharyngitis: inflammation extending from tonsils to the adenoids and lingual tonsils recurrent tonsillitis: 7 episodes in 1 year, 5 infections in 2 consecutive years, or 3 infections each year for 3 years consecutively chronic tonsillitis: chronic sore throat, halitosis, tonsillitis, and persistent tender cervical nodes for greater than 4 weeks quinsy: Greek term used for inflammation of throat and tonsils, historically used for peritonsillar abscess
Epidemiology most cases occur in school-age children uncommon in the first 2 years of life 5-7 URIs per child per year GAS is found in 35% of children with pharyngitis 45,000 cases of PTA per year or 30 cases per 100,000 people per year
Causes of Tonsillopharyngitis Beta hemolytic streptococcal infection 22 percent Mycoplasma pneumoniae 9.4 percent Chlamydia species strain TWAR 8.4 percent Viruses 25.5 percent Huovinen, et al 1995
CLINICAL DIAGNOSIS The "classic" presentation of GAS tonsillopharyngitis is a sore throat associated with fever, tonsillopharyngeal erythema and exudate, swollen and tender anterior cervical adenopathy, and an elevated white blood cell (WBC) count without rhinorrhea or cough. However, even when this constellation of clinical symptoms is present, the likelihood of GAS infection does not exceed 60 to 70 percent in children, and 20 to 30 percent in adults.
Is it truly Group A beta hemolytic Streptoccal tonsillopharyngitis? From many studies, it would appear that the presence or absence of a GAS pharyngitis cannot be accurately diagnosed with clinical examination alone in most patients. It is somewhat easier to identify a subset of children (approximately 20 percent of cases) and adults (approximately 67 percent of cases) who are unlikely to have GAS. These patients have sore throats with accompanying rhinorrhea, cough, and hoarseness. Fever is often absent. They have mild tonsillopharyngeal erythema without exudate, and slight or no cervical lymphadenitis.
Why antibiotics Treatment of GABHS pharyngitis is important To prevent complications of infection, particularly rheumatic fever suppurative complications To speed recovery To prevent spread of the infection
Treatment approach based on clinical findings (Komarof, et al) Empirically treat patients with the constellation of a tonsillar exudate, tender cervical adenopathy, and a temperature >37.8º C. Obtain throat cultures in patients with only one or two of the above findings and treat based upon those results. Do not obtain cultures or treat patients with none of the above findings.
The nonsuppurative complications of GAS tonsillopharyngitis Acute rheumatic fever Scarlet fever Streptococcal toxic shock syndrome Acute glomerulonephritis PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder Associated with Group A Streptococci)
Suppurative complications Tonsillopharyngeal cellulitis or abscess Otitis media Sinusitis Necrotizing fasciitis
Mononucleosis epstein-barr virus (EBV indolent onset, gray tonsillar exudate, tender cervical, axillary and/or inguinal lymphadenopathy, low grade fever, weight loss, myalgias, fatigue, hepatosplenomegaly atypical lymphocytes in peripheral smear positive monospot or heterophil Ab test rash with penicillin illness lasts more than 7-10 days
Intraoral Ultrasound highly accurate ultrasound can exclude peritonsillar cellulitis, abscess and retropharyngeal abscess determination of abscess volume, location and relationship to carotid artery
CT neck with contrast indications: spread to deep neck structures inferior pole abscess high risk for drainage procedures (coagulopathy) to guide drainage of PTA after unsuccessful surgical attempt patient unable to open mouth due to trismus
complicated PTA with rupture into carotid space
Recommendations on the Management of Acute and Chronic Tonsillitis Adequate supportive care Use of analgesics, oral anesthetics, and antiseptics Antibiotics
Penicillins Cephalosporins Macrolides
in the AHA guidelines, prevention of rheumatic fever as a poststreptococcal complication depends on eradication of GABHS bacteria from the pharynx prevention of rheumatic fever and other nonsuppurative complications of GABHS pharyngitis still occurs when antibacterial therapy is postponed by as many as 9 days after the onset of pharyngitis symptoms
Factors influencing antibiotic choice ability to eradicate GABHS bacteria from the pharynx Ability to resolve signs and symptoms of the infection (bacteriologic and clinical efficacy) adherence (frequency of daily administration, duration of therapy, and palatability), Antibacterial spectrum (narrow versus broad activity), potential treatment-related side effects cost.
Changing pattern of penicillin sensitivity
Short course therapy of AT Cephalopsorin Azithromycin
Penicillin Resistance: Mechanism It is important to note that no strains of GABHS resistant to penicillin or cephalosporin have ever been reported. Copathogenicity is the most likely explanation for the increasing rate of penicillin treatment failures GABHS susceptible to penicillin are protected by other in vivo, colocalized bacteria that lack the same susceptibility due to beta-lactamase production beta-lactamase producing organisms is more likely to inactivate penicillin
Recurrence risk Symptomatic bacteriologic recurrence within 30 days of initial diagnosis occurred in 37% of patients treated with penicillin V, 25% of patients treated with amoxicillin, 18% of patients treated with cephalexin or cefadroxil, 7% of patients treated with amoxicillin-clavulanate or a second-generation or third-generation cephalosporin
Children Less Than Three-Years-Old With Pharyngitis Are Group A Streptococci Really That Uncommon Clinical pediatrice, 1986 During a 15-month period, 148 infants and children less than 3-years- old who presented with signs and/or symptoms of pharyngitis were monitored in a private pediatric practice. Clinical signs included fever (95 or 64%), tonsillar exudate (16 or 11%), and cervical adenopathy (5 or 3%). Beta-hemolytic streptococci (BHS) from group A were isolated from throat swabs in 37 (25%) instances. These isolations were more common among children 25-35 months old than among children less than 2 years old (35% vs. 19%, p < 0.05), and were significantly more likely when overnight anaerobic culture techniques were used rather than conventional aerobic methods (23 % vs. 11%, p < 0.01).
Recurrent tonsillitis Recurrent tonsillitis is diagnosed when an individual has 7 episodes in 1 year, 5 infections in 2 consecutive years, or 3 infections each year for 3 years consecutively.
Microbiology of recurrent tonsillitis A polymicrobial flora consisting of both aerobic and anaerobic bacteria is observed in core tonsillar cultures from cases of recurrent pharyngitis. Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae are the most common bacteria isolated in recurrent tonsillitis. Bacteroides fragilis is the most common anaerobic bacterium isolated in recurrent tonsillitis. A polymicrobial bacterial population is observed in most cases of chronic tonsillitis, with alpha- and beta-hemolytic streptococcal species, S aureus, H influenzae, and Bacteroides species identified. One study, based on bacteriology of the tonsillar surface and core in 30 children undergoing tonsillectomy, suggests that antibiotics prescribed 6 months before surgery do not alter the tonsillar bacteriology at the time of tonsillectomy. 7 7 A relationship between tonsillar size and chronic bacterial tonsillitis is believed to exist. This relationship is based on both the aerobic bacterial load and the absolute number of B and T lymphocytes. H influenzae is the bacterium most often isolated in hypertrophic tonsils and adenoids. With regard to penicillin resistance or beta-lactamase production, the microbiology of tonsils removed from patients with recurrent GABHS pharyngitis is not significantly different from the microbiology of tonsils removed from patients with tonsillar hypertrophy.
Treatment for recurent / chronic tonsillitis Clindamycin: 20-30 mg/kg PO divided tid for 10 d not to exceed 300 mg/dose + Rifampin: 10 mg/kg/dose bid for 4 days Amoxy-clav for 4-6 weeks
Prophylaxis (5 strep infections in 6 months) Penicillin V Potassium (Kaypen)40 mg/kg/day PO bid, max 3 gm/day
Tonsillectomy: Absolute Indications Tonsillar hypertrophy causing obstruction to respiration or deglutition Obstructive sleep apnea